secwatch.observer — SEC 8-K summary
======================================

Issuer:     SomaLogic, Inc. (—)
CIK:        0001837412
Form:       8-K
Filed at:   2024-01-05T23:59:59+00:00
Accession:  0001104659-24-001828
Event type: m_and_a
Sentiment:  neutral
Materiality: 1.00
Item codes: 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SomaLogic completes merger with Standard BioTools; each share converted into 1.11 Standard BioTools shares
--------------------------------------------------------------------------------

- Merger closed Jan 5, 2024; SomaLogic now wholly owned subsidiary of Standard BioTools.
- Each SomaLogic share converted into 1.11 shares of Standard BioTools common stock; fractional shares paid in cash.
- Stockholders approved merger (102.4M for, 41.6M against); SomaLogic Board resigned and new board appointed.
- SomaLogic common stock and warrants to be delisted from Nasdaq; Form 15 to terminate SEC reporting.
- All outstanding SomaLogic options and RSUs assumed by Standard BioTools, adjusted by exchange ratio.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1837412/000110465924001828/0001104659-24-001828-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1837412/000110465924001828/tm242079d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-001828

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer